VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 143 filers reported holding VIKING THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.72 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,096,000 | +13.2% | 365,354 | +73.7% | 0.00% | – |
| Q4 2021 | $968,000 | -50.3% | 210,376 | -32.1% | 0.00% | -100.0% |
| Q3 2021 | $1,946,000 | +6.7% | 309,936 | +1.9% | 0.00% | 0.0% |
| Q2 2021 | $1,823,000 | +11.0% | 304,302 | +17.2% | 0.00% | 0.0% |
| Q1 2021 | $1,642,000 | +52.3% | 259,572 | +35.6% | 0.00% | 0.0% |
| Q4 2020 | $1,078,000 | +28.5% | 191,405 | +32.8% | 0.00% | 0.0% |
| Q3 2020 | $839,000 | -23.9% | 144,078 | -5.7% | 0.00% | 0.0% |
| Q2 2020 | $1,102,000 | +80.7% | 152,836 | +17.3% | 0.00% | 0.0% |
| Q1 2020 | $610,000 | -78.5% | 130,349 | -63.1% | 0.00% | -50.0% |
| Q4 2019 | $2,833,000 | +321.6% | 353,228 | +261.8% | 0.00% | +100.0% |
| Q3 2019 | $672,000 | -21.4% | 97,632 | -5.2% | 0.00% | 0.0% |
| Q2 2019 | $855,000 | -40.7% | 103,027 | -29.0% | 0.00% | 0.0% |
| Q1 2019 | $1,443,000 | -21.3% | 145,198 | -39.4% | 0.00% | -50.0% |
| Q4 2018 | $1,834,000 | -57.6% | 239,693 | -3.4% | 0.00% | -50.0% |
| Q3 2018 | $4,324,000 | +70.5% | 248,235 | -7.1% | 0.00% | +100.0% |
| Q2 2018 | $2,536,000 | +715.4% | 267,247 | +275.9% | 0.00% | – |
| Q1 2018 | $311,000 | – | 71,096 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 450,900 | $2,624,000 | 0.85% |
| Sio Capital Management, LLC | 709,780 | $4,131,000 | 0.82% |
| KNOTT DAVID M | 218,102 | $1,269,000 | 0.74% |
| ArrowMark Colorado Holdings LLC | 7,988,635 | $46,494,000 | 0.44% |
| Park West Asset Management LLC | 1,457,507 | $8,483,000 | 0.33% |
| VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. | 1,657 | $10,000 | 0.18% |
| Virtus ETF Advisers LLC | 42,507 | $247,000 | 0.13% |
| Cornerstone Capital, Inc. | 125,465 | $730,000 | 0.10% |
| L & S Advisors Inc | 114,988 | $669,000 | 0.09% |
| EXANE DERIVATIVES | 44,877 | $261,170,000 | 0.08% |